MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202611054463 A) filed by Dr. Juhi Aggarwal; Dr. Himanshu Shekhar; and Santosh Deemed To Be University on April 29, 2026, for Method For Assessing Insulin Resistance In Patients With Chronic Obstructive Pulmonary Disease Using.
Inventors include Dr. Juhi Aggarwal; and Dr. Himanshu Shekhar.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: The present invention relates to a method and system for assessing metabolic dysfunction in subjects with Chronic Obstructive Pulmonary Disease (COPD). The method comprises obtaining a biological sample from a subject, measuring glucose-related and insulin-related parameters, computing an insulin resistance index using a predefined algorithm, and generating a metabolic risk assessment associated with COPD. In certain embodiments, lipid-based metabolic indices, anthropometric parameters, and pulmonary function measurements are evaluated to determine disease severity and metabolic status. The invention provides an integrated diagnostic framework for identifying insulin resistance and metabolic abnormalities in COPD patients using clinically accessible measurements. The method is applicable in clinical diagnostic systems, hospitals, and research settings for metabolic risk evaluation and disease assessment.
Disclaimer: Curated by HT Syndication.
